Journal article
The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada
Abstract
Purpose: Fluoro-2-deoxyglucose positron-emission tomography (FDG-PET/CT) is now considered a standard investigation for the staging of new cases of stage III NSCLC. However, there is not published level 3 evidence demonstrating the impact of FDG-PET/CT on appropriate therapy in this setting. Using retrospective population-based data, we sought to examine the role and timing that FDG-PET/CT scans play in influencing treatment choice, as well as …
Authors
Beers CA; Pond GR; Wright JR; Tsakiridis T; Okawara GS; Swaminath A
Journal
Frontiers in Oncology, Vol. 13, ,
Publisher
Frontiers
DOI
10.3389/fonc.2023.1210945
ISSN
2234-943X